Market Tracker

04/01 6:02pm ET

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

26.00
Delayed Data
As of Apr 01
 -0.17 / -0.65%
Today’s Change
19.10
Today|||52-Week Range
47.65
+24.16%
Year-to-Date

Today’s Trading

Previous close26.17
Today’s open26.20
Day’s range25.35 - 26.20
Volume648,811
Average volume (3 months)658,283
Market cap$746.9M
Dividend yield--
Data as of 3:59pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)+38.36%
Earnings growth (this year)-11.48%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+226.23%
P/E ratioNM
Price/Sales3.84
Price/Book4.65

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.10-0.32%
IMGNImmunoGen Inc-0.01-0.11%
ANIPANI Pharmaceuticals ...+1.21+1.93%
RTRXRetrophin Inc-0.35-1.46%
Data as of 4:00pm ET, 04/01/2015

Financials

Next reporting dateApril 28, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$158.4M
Annual profit (last year)-$39.4M
Net profit margin-24.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc D. Beer
Chief Operating Officer
Craig E. Fraser
Corporate headquarters
Cambridge, Massachusetts

Forecasts